Hydrix Limited · ASX:HYD

Hydrix — Investor Presentation (April 2019)

20 slides from Hydrix's investor presentation, Apr 2, 2019

  1. Slide 1: Hydrix Ltd Investor Update

    For personal use only Hydrix Ltd Investor Update April 2019 Development and commercialisation of technologies that enhance people’s health, safety and well-being Slide 1 Hydrix | Investor Update | 1 April 2019

  2. Slide 2: Disclaimer

    Disclaimer For personal use only This presentation has been prepared by Hydrix Limited (the “Company” or “Hydrix”). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business ac

  3. Slide 3: Hydrix today

    Hydrix today For personal use only Hydrix brings together a unique set of skills to solve complex problems and develop pioneering technology in large, fast growing, global target markets Hydrix’s capabilities include: Medical Tech Critical systems • Rail (AUD$100bn over next • Software • Cardiac dec

  4. Slide 4: A diversified fee-for-service product design & commercialisation business

    A diversified fee-for-service product design & commercialisation business For personal use only  Develop pioneering technology to deliver successful product innovation for our clients  Breadth of capability from idea generation to commercialisation  Delivered 200+ products over the last 15 years

  5. Slide 5: A proven portfolio of projects, clients and industries

    A proven portfolio of projects, clients and industries For personal use only Slide 5 Hydrix | Investor Update | 1 April 2019

  6. Slide 6: A diverse array of sophisticated design projects

    A diverse array of sophisticated design projects For personal use only Selection of Current Projects: Cardiac Assist Devices for Heart Failure Patients • Currently operating three simultaneous projects: UK, France & USA (Inc. total artificial heart) Powered robotic exoskeleton for stroke victims Nex

  7. Slide 7: Delivering strong revenue growth

    Delivering strong revenue growth For personal use only Audited Quarterly Revenue (#039;000) $3,500 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $0 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18 Slide 7 Hydrix | Investor Update | 1 April 2019

  8. Slide 8: Met or exceeded all 1H FY19 milestones

    Met or exceeded all 1H FY19 milestones For personal use only Milestones 1H FY19 Updates Minimum 15% revenue growth Exceeded  1H19 revenue of $5.7m represents compared to 2H18 43% growth on 2H18 revenues of $4.0m 15% increase in engineering Exceeded  25% headcount increase in services capacity engi

  9. Slide 9: On track to meet or exceed 2H FY19 milestones

    On track to meet or exceed 2H FY19 milestones For personal use only Milestone Aspirations 2H FY19 Status Minimum 15% revenue growth in H2 On Track compared to H1 Solidify global leadership position engineering On Track cardiac assistance control devices Secure three significant and high-dollar value

  10. Slide 10: A vision and clear strategy that drives growth

    A vision and clear strategy that drives growth For personal use only Development and commercialisation of technologies that will Vision enhance people’s health, safety and well-being To be a sought-after world class developer and provider of pioneering Mission technology products & services Increase

  11. Slide 11: Growth from fee-for-design services, buying & building pioneering products

    Growth from fee-for-design services, buying & building pioneering products and making strategic investments in customers For personal use only Hydrix provides a unique opportunity to gain access to a diversified technology development and products company at the start of its growth trajectory Divers

  12. Slide 12: Well placed for future growth

    Well placed for future growth For personal use only In summary, we have: • Clear vision and strategy for growth in providing services and developing our own products for fast-growing target markets • Increasing global demand for our advanced engineering and design services developed over 15+ years •

  13. Slide 13: Appendix: Corporate and Board overview

    For personal use only Appendix 1 Corporate and Board overview

  14. Slide 14: A long term, supportive shareholder base

    A long term, supportive shareholder base For personal use only Capital Structure (as of 28 Mar. 2019) Major Shareholders Shares (m) % Ticker HYD John W King Nominees 144 22% Share Price $0.02 Lion Tail Trading Pty Ltd* 43 7% Shares on Issue (m) 669.1 Kurrawonga Pty Ltd 19 3% Options and Performance

  15. Slide 15: A highly experienced board & executive leadership team

    A highly experienced board & executive leadership team For personal use only The Hydrix Board and Executive Team possess wide ranging experience and proven skills across: Finance, Strategy, Governance, Capital Markets, Technology, IP and our target industry sectors of MedTech, Industrial, Consumer a

  16. Slide 16: Appendix: Selected fee-for-service project case studies

    For personal use only Appendix 2 Selected fee-for-service project case studies

  17. Slide 17: Design & Manufacture of Advanced Rail Communications System

    Proven Track Record – Design & Manufacture of Advanced Rail Communications System For personal use only Radio Interface Unit for Victorian Digital Train Radio System • Provides Global Navigation Satellite System (GNSS), telemetry, data & communications • Interface to digital radios, analogue radios

  18. Slide 18: End to End Design & Development of Unique X-Ray System

    Proven Track Record – End to End Design & Development of Unique X-Ray System For personal use only Portable radiography using nanotechnology (from concept to FDA certification in 18 months) • Software development (power management & x-ray fire control) • Software HMI Design and Development • Human F

  19. Slide 19: Design of Controller for a Total Artificial Heart

    Proven Track Record – Design of Controller for a Total Artificial Heart For personal use only Development of control systems for Ventricular Assist Devices (LVADs) and Total Artificial Hearts (TAHs) • Hydrix is a world leader in developing this technology • Hydrix has completed two successful clinic

  20. Slide 20: hydrix.com

    For personal use only hydrix.com 30-32 Compark Circuit Mulgrave VIC 3170 Australia ASX:HYD Slide 20 Hydrix | Investor Update | 1 April 2019

Hydrix — Investor Presentation (April 2019) on 6ix